Livestock Vaccine Innovation Fund: Strengthening of Research Capacity
This project creates the authorization for capacity building support to develop and manage the Livestock Vaccine Innovation Fund (LVIF). The fund aims to support the development of quality vaccines that are more affordable, available, and acceptable to small-scale farmers. It will also help ensure their use at scale.
About the Livestock Vaccine Innovation Fund
The LVIF is a partnership between the Bill & Melinda Gates Foundation, Global Affairs Canada (formerly Foreign Affairs, Trade and Development Canada), and the International Development Research Centre. It represents a joint investment of CA$57 million over five years to support the development, production, and commercialization of innovative vaccines against priority livestock diseases in sub-Saharan Africa, South Asia, and Southeast Asia.
More specifically, the LVIF will support innovation and research to increase the efficacy, marketability, and use of existing vaccines, develop new vaccines against priority livestock diseases, and build effective research and public-private partnerships to accelerate the registration, commercialization, and use of vaccines.
The research will also lead to a better understanding of disease dynamics and their impact, as well as the issues that constrain poor farmers from using vaccines. By bringing together all stakeholders - from farmers to researchers, pharmaceutical companies, and regulators - the LVIF will foster a vibrant and sustainable livestock sector in the target regions.
Separate Project Approval Documents will authorize individual research projects and activities related to research uptake and scale up, program synthesis, and communication.